Effect of Vecam 40/300 and Vecam 20/300 Compared to Omeprazole 20 mg on Gastric pH

Clinical trial NCT00818870 · COMPLETED

Trial details

NCT number: NCT00818870
Sponsor: Vecta Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Gastroesophageal Reflux

Start date: 2008-12-01
Primary completion: 2009-06-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.